STROKE PREVENTION AND THYROID SCREENING

THYROID CANCER SCREENING

Home | STROKE PREVENTION SCREENING | CAROTID INTIMA MEDIA THICKNESS (CIMT) | THYROID CANCER SCREENING | WHAT IS STROKE PREVENTION & THYROID SCREENING | Payment and FAQ's | REFERENCES

Thyroid Cancer Screening

The American Cancer Society estimates that in 1997, over 16,000 cases of thyroid cancer were treated.  Most people with thyroid cancer are between the ages of 25 and 65, with the majority being women.  This disease makes up approximately 1.2% of all cancers.

 Although most Americans believe that thyroid cancer is rare, according to the American Association of Clinical Endocrinologists, however, it effects about the same number as cervical cancer.  As with most cancers, the earlier the intervention the better the prognosis.  In fact, more than 95% of those diagnosed with the common type of thyroid cancer are still alive after 20 years.  Strokescreen.com's Thyroid Screening was developed to pinpoint those people who have thyroid nodules at an early stage.  A nodule is a hard mass located in the thyroid gland.  The thyroid gland is located at the front of the neck, below the “Adam’s Apple”.  Using high-resolution ultrasound, a technician places a transducer on the neck over the thyroid gland and ”looks" at the gland.  Nodules, if present, are measured and a picture is taken for the use of that person’s physician. Frequently, the physician will order a blood test and/or a thyroid scan to determine whether there is something of concern.  Because thyroid nodules very rarely cause symptoms, a nodule could be cancerous, therefore follow-up measures are recommended.  If there is question of cancer, further testing, often a needle biopsy may be ordered to make final diagnosis.

Questions or comments? Get in touch with us at: